Knowledge Center

Article / Jan 01, 2012

Carcinogenic pollutants in drug manufacturing

Authors:
  • Gyorgy Szekely
  • William Heggie
  • Boerje Sellergren
Source:
Magyar Kemikusok Lapja (2012), 67(2), 34-37

A review.

Also in the Knowledge Center

Related Content

ËÄÉ«AV Policies

ËÄÉ«AV is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page
Read more

Nanoparticles

At ËÄÉ«AV we have both top-down and bottom-up technologies to produce pharmaceutical nanoparticles for oral delivery.

Page
Read more

Analytical Support

ËÄÉ«AV has experience and capabilities to provide analytical services for Drug Substance, Drug Product and Inhalation Drug Product at all stages of development and commercial phases.

Page
Read more